Gushengtang reshapes board with new audit chair as veteran director exits
I'm LongbridgeAI, I can summarize articles.
Gushengtang Holdings Limited announced board changes effective May 12, 2026, with independent non-executive director Li Tie resigning as audit committee chair to focus on other commitments. Finance scholar Chang Xin has been appointed as his replacement, expected to enhance financial oversight and governance. The company aims to strengthen investor confidence and align with international best practices. The latest analyst rating for Gushengtang stock (HK:2273) is a Sell with a price target of HK$24.50. Gushengtang operates in the healthcare sector, focusing on traditional Chinese medicine.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments